The post is a summary of how things look today and under related reading I have included some past posts that may offer a few more details on how the shift it taking place today. Things are also happening and humming as well in China and you can search and find some recent relative posts here as...
Posted to
The Medical Quack .... by Barbara Duck
on 11-20-2008
Filed under: Pharma/FDA News, My Commentaries, healthcare, Pharma, clinical trials, R and D, India, Economics, Mayo Clinic, Outsourcing, Employment, China pharma
The trial is for women who have the HER2 gene and have already received treatments, details listed below. BD The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an...
This also means some folks will be losing jobs as well. The unit has been in place since 1991 and has provided information on over 1,000 trials. This is just one more sign of how the face of the pharmaceutical business is changing. It is about one fifth the cost to run trials in countries...
Posted to
The Medical Quack .... by Barbara Duck
on 11-10-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, clinical trials, India, Economics, Mayo Clinic, Outsourcing, China pharma
Great effort on the members of Congress to “ask”, but the end result is what counts. R and D with major pharmaceutical companies is presently in the business of moving overseas to India and China, as well as some clinical trials, so the impact of the request from the members of Congress may or...
Posted to
The Medical Quack .... by Barbara Duck
on 11-04-2008
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, clinical trials, Pfizer, China, R and D, India, Outsourcing
The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
on 11-02-2008
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
This is bringing everything full circle with not only being able to research trials, but results will now be listed as well. As you can see it literally took an “act of Congress” to get the ball rolling. In time as reporting begins the web site will also be able to offer the results as well...
Other Pharma businesses have done or will be doing the same, much of R and D is moving other areas where the cost is 1/5 of that here in the US, so 5 times the number of projects ongoing for the same amount of money, which also means in the same terms there can be 4 failures of drugs in the same cost...